Standard Biotools Inc. (LAB) insider trading.
In Q3 2026, insiders at Standard Biotools Inc. reported 5 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 3
- Last filed
- 2026-08-24
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Egholm Michael | Director, Officer · President & CEO | 2 | 0 | 0 |
| Kim Hanjoon Alex | Officer · Chief Financial Officer | 2 | 0 | 0 |
| Mackay Sean | Officer · SVP & Chief Business Officer | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-20 | Egholm Michael | F (D) | 97,627 | $0.67 | 6,137,704 | Form 4 |
| 2026-08-20 | Kim Hanjoon Alex | F (D) | 28,195 | $0.67 | 2,534,859 | Form 4 |
| 2026-08-20 | Mackay Sean | F (D) | 25,729 | $0.67 | 1,480,823 | Form 4 |
| 2026-08-03 | Egholm Michael | F (D) | 362,625 | $0.87 | 6,235,331 | Form 4 |
| 2026-07-23 | Kim Hanjoon Alex | F (D) | 202,476 | $0.9 | 2,563,054 | Form 4 |
Transaction codes in this quarter
Get LAB insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1162194&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · LAB company page · Standard Biotools Inc. on SEC.gov
Questions
Are insiders buying or selling Standard Biotools Inc. (LAB)?
In Q3 2026, insiders at Standard Biotools Inc. reported 5 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Standard Biotools Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/lab.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.